SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Igor A. Pomytkin, Brandon H. Cline, Daniel C. Anthony, Harry W. Steinbusch, Klaus-Peter Lesch, Tatyana Strekalova, Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance?, Behavioural Brain Research, 2015, 276, 111

    CrossRef

  2. 2
    Xinguo Ren, Hooriyah S. Rizavi, Mansoor A. Khan, Runa Bhaumik, Yogesh Dwivedi, Ghanshyam N. Pandey, Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia, Journal of Affective Disorders, 2014, 152-154, 326

    CrossRef

  3. 3
    Vivek Gupta, Nitin Chitranshi, Yuyi You, Veer Gupta, Alexander Klistorner, Stuart Graham, Brain derived neurotrophic factor is involved in the regulation of glycogen synthase kinase 3β (GSK3β) signalling, Biochemical and Biophysical Research Communications, 2014, 454, 3, 381

    CrossRef

  4. 4
    Sung Woo Park, Jung Goo Lee, Mi Kyoung Seo, Hye Yeon Cho, Chan Hong Lee, Ji Heon Lee, Bong Ju Lee, Jun Hyung Baek, Wongi Seol, Young Hoon Kim, Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons, Bipolar Disorders, 2014, 16, 7
  5. 5
    Sung Jin Kwon, Kwang Seop Song, Hwajin Kim, Yoon Sook Kim, Wan Sung Choi, Sun Ok Kwon, Low-intensity treadmill exercise and bright light upregulate brain-derived neurotrophic factor expression and intracellular signaling pathway in rat hippocampus and cerebral cortex, Animal Cells and Systems, 2014, 18, 2, 135

    CrossRef

  6. 6
    Myoung Suk Seo, Elizabeth Scarr, Chi-Yu Lai, Brian Dean, Potential Molecular and Cellular Mechanism of Psychotropic Drugs, Clinical Psychopharmacology and Neuroscience, 2014, 12, 2, 94

    CrossRef

  7. 7
    Benicio N Frey, Rodrigo S Dias, Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder, Bipolar Disorders, 2014, 16, 1
  8. 8
    Xinguo Ren, Hooriyah S. Rizavi, Mansoor A. Khan, Yogesh Dwivedi, Ghanshyam N. Pandey, Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin, The International Journal of Neuropsychopharmacology, 2013, 16, 05, 945

    CrossRef

  9. 9
    Tsukasa Kawaguchi, Takahiro Kodama, Hayato Hikita, Satoshi Tanaka, Minoru Shigekawa, Takatoshi Nawa, Satoshi Shimizu, Wei Li, Takuya Miyagi, Naoki Hiramatsu, Tomohide Tatsumi, Tetsuo Takehara, Carbamazepine promotes liver regeneration and survival in mice, Journal of Hepatology, 2013, 59, 6, 1239

    CrossRef

  10. 10
    Se Hyun Kim, Hyun Sook Yu, Hong Guen Park, Yong Min Ahn, Yong Sik Kim, Young Han Lee, Kyooseob Ha, Soon Young Shin, Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 12, 1969

    CrossRef

  11. 11
    Raffaella Calati, Concetta Crisafulli, Martina Balestri, Alessandro Serretti, Edoardo Spina, Marco Calabrò, Antonina Sidoti, Diego Albani, Isabelle Massat, Peter Höfer, Daniela Amital, Alzbeta Juven-Wetzler, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Julien Mendlewicz, Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013, 44, 271

    CrossRef

  12. 12
    Adam R. Cole, Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia, FEBS Journal, 2013, 280, 21
  13. 13
    Andrea de Bartolomeis, Livia Avvisati, Felice Iasevoli, Carmine Tomasetti, Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment, European Journal of Pharmacology, 2013, 718, 1-3, 502

    CrossRef

  14. 14
    Monika Dmitrzak-Weglarz, Jerzy Moczko, Maria Skibinska, Agnieszka Slopien, Marta Tyszkiewicz, Joanna Pawlak, Dorota Zaremba, Aleksandra Szczepankiewicz, Andrzej Rajewski, Joanna Hauser, The study of candidate genes related to the neurodevelopmental hypothesis of anorexia nervosa: Classical association study versus decision tree, Psychiatry Research, 2013, 206, 1, 117

    CrossRef

  15. 15
    Wenjun Zhou, Ligong Chen, Sufen Yang, Fuzeng Li, Xiaohua Li, Behavioral Stress-Induced Activation of FoxO3a in the Cerebral Cortex of Mice, Biological Psychiatry, 2012, 71, 7, 583

    CrossRef

  16. 16
    Eléonore Beurel, Marjelo A Mines, Ling Song, Richard S Jope, Glycogen synthase kinase-3 levels and phosphorylation undergo large fluctuations in mouse brain during development, Bipolar Disorders, 2012, 14, 8
  17. 17
    Se-Jin Jeon, Hae-Rang Bak, Jung-Eun Seo, So-Min Han, Sung-Hoon Lee, Seol-Heui Han, Kyoung-Ja Kwon, Jong-Hoon Ryu, Jae-Hoon Cheong, Kwang-Ho Ko, Sung-Il Yang, Ji-Woong Choi, Seung-Hwa Park, Chan-Young Shin, Oroxylin A Induces BDNF Expression on Cortical Neurons through Adenosine A2AReceptor Stimulation: A Possible Role in Neuroprotection, Biomolecules and Therapeutics, 2012, 20, 1, 27

    CrossRef

  18. 18
    Xiaohua Li, Mark A Frye, Richard C Shelton, Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development, Neuropsychopharmacology, 2012, 37, 1, 77

    CrossRef

  19. 19
    Tatiana V. Lipina, Min Wang, Fang Liu, John C. Roder, Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice, Neuropharmacology, 2012, 62, 3, 1252

    CrossRef

  20. 20
    Se Hyun Kim, Soon Young Shin, Kyu Young Lee, Eun Jeong Joo, Joo Youn Song, Yong Min Ahn, Young Han Lee, Yong Sik Kim, The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 37, 1, 41

    CrossRef

  21. You have free access to this content21
    Jana Hroudová, Zdeněk Fišar, Connectivity between mitochondrial functions and psychiatric disorders, Psychiatry and Clinical Neurosciences, 2011, 65, 2
  22. 22
    Miguel Medina, Francisco Wandosell, Deconstructing GSK-3: The Fine Regulation of Its Activity, International Journal of Alzheimer's Disease, 2011, 2011, 1

    CrossRef

  23. 23
    Dinesh C. Soares, Becky C. Carlyle, Nicholas J. Bradshaw, David J. Porteous, DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness, ACS Chemical Neuroscience, 2011, 2, 11, 609

    CrossRef

  24. 24
    Shuken Boku, Shin Nakagawa, Takahiro Masuda, Hiroyuki Nishikawa, Akiko Kato, Hiroyuki Toda, Ning Song, Yuji Kitaichi, Takeshi Inoue, Tsukasa Koyama, Effects of mood stabilizers on adult dentate gyrus-derived neural precursor cells, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011, 35, 1, 111

    CrossRef

  25. 25
    Tatiana V. Lipina, Oksana Kaidanovich-Beilin, Satish Patel, Min Wang, Steven J. Clapcote, Fang Liu, James R. Woodgett, John C. Roder, Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3, Synapse, 2011, 65, 3
  26. 26
    Zhaoxu Zhang, Ruiping Zhao, Jiping Qi, Shirong Wen, Ying Tang, Desheng Wang, Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons, Journal of Neuroscience Research, 2011, 89, 3
  27. 27
    Inbal Lahiani-Cohen, Athanasios Lourbopoulos, Ester Haber, Lea Rozenstein-Tsalkovich, Oded Abramsky, Nikolaos Grigoriadis, Hanna Rosenmann, Moderate Environmental Enrichment Mitigates Tauopathy in a Neurofibrillary Tangle Mouse Model, Journal of Neuropathology and Experimental Neurology, 2011, 70, 7, 610

    CrossRef

  28. 28
    Breno Satler Diniz, Leda Leme Talib, Helena Passarelli Giroud Joaquim, Vanessa Rodrigues Jesus de Paula, Wagner Farid Gattaz, Orestes Vicente Forlenza, Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment?, World Journal of Biological Psychiatry, 2011, 12, 3, 216

    CrossRef

  29. 29
    Marjelo A. Mines, Eleonore Beurel, Richard S. Jope, Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3, International Journal of Alzheimer's Disease, 2011, 2011, 1

    CrossRef

  30. 30
    Abigail Polter, Eléonore Beurel, Sufen Yang, Rakesha Garner, Ling Song, Courtney A Miller, J David Sweatt, Lori McMahon, Alfred A Bartolucci, Xiaohua Li, Richard S Jope, Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances, Neuropsychopharmacology, 2010,

    CrossRef

  31. 31
    Jung Goo Lee, Hye Yeon Cho, Sung Woo Park, Mi Kyoung Seo, Young Hoon Kim, Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010, 34, 6, 1001

    CrossRef

  32. 32
    Naoto Oikawa, Koichi Ogino, Takumi Masumoto, Haruyasu Yamaguchi, Katsuhiko Yanagisawa, Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse, Neuroscience Letters, 2010, 468, 3, 243

    CrossRef

  33. 33
    Kerang Zhang, Chunxia Yang, Yong Xu, Ning Sun, Hong Yang, Jinli Liu, Qi Xu, Yan Shen, Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population, Journal of Neural Transmission, 2010, 117, 3, 393

    CrossRef

  34. 34
    Ghanshyam N. Pandey, Xinguo Ren, Hooriyah S. Rizavi, Yogesh Dwivedi, Glycogen synthase kinase-3β in the platelets of patients with mood disorders: Effect of treatment, Journal of Psychiatric Research, 2010, 44, 3, 143

    CrossRef

  35. You have free access to this content35
    S Phukan, VS Babu, A Kannoji, R Hariharan, VN Balaji, GSK3β: role in therapeutic landscape and development of modulators, British Journal of Pharmacology, 2010, 160, 1
  36. 36
    Xiaohua Li, Richard S Jope, Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?, Neuropsychopharmacology, 2010, 35, 11, 2143

    CrossRef

  37. 37
    Zu-Fu Zhu, Qing-Guang Wang, Bo-Jun Han, Callie P. William, Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice, Brain Research Bulletin, 2010, 83, 5, 272

    CrossRef

  38. 38
    Xiaohong Li, Min Liu, Zhuoji Cai, Gang Wang, Xiaohua Li, Regulation of glycogen synthase kinase-3 during bipolar mania treatment, Bipolar Disorders, 2010, 12, 7
  39. 39
    J. N. Talbot, E. M. Jutkiewicz, S. M. Graves, C. F. Clemans, M. R. Nicol, R. M. Mortensen, X. Huang, R. R. Neubig, J. R. Traynor, RGS inhibition at G i2 selectively potentiates 5-HT1A-mediated antidepressant effects, Proceedings of the National Academy of Sciences, 2010, 107, 24, 11086

    CrossRef

  40. 40
    Chunxia Yang, Yong Xu, Ning Sun, Yan Ren, Zhifen Liu, Xiaohua Cao, Kerang Zhang, The combined effects of the BDNF and GSK3B genes modulate the relationship between negative life events and major depressive disorder, Brain Research, 2010, 1355, 1

    CrossRef

  41. 41
    Tae-Yeon Eom, Richard S. Jope, Blocked Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3α/β Impairs In Vivo Neural Precursor Cell Proliferation, Biological Psychiatry, 2009, 66, 5, 494

    CrossRef

  42. 42
    Yunyoung C. Chang, Stanley I. Rapoport, Jagadeesh S. Rao, Chronic Administration of Mood Stabilizers Upregulates BDNF and Bcl-2 Expression Levels in Rat Frontal Cortex, Neurochemical Research, 2009, 34, 3, 536

    CrossRef

  43. 43
    Abigail Polter, Sufen Yang, Anna A. Zmijewska, Thomas van Groen, Ji-Hye Paik, Ronald A. DePinho, Stanford L. Peng, Richard S. Jope, Xiaohua Li, Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation, Biological Psychiatry, 2009, 65, 2, 150

    CrossRef

  44. You have free access to this content44
    Sung Woo Park, Jung Goo Lee, Bo Geum Kong, Sun Jung Lee, Chan Hong Lee, Jeong Ik Kim, Young Hoon Kim, Genetic association of BDNF val66met and GSK-3β-50T/C polymorphisms with tardive dyskinesia, Psychiatry and Clinical Neurosciences, 2009, 63, 4
  45. 45
    Ghanshyam N. Pandey, Yogesh Dwivedi, Hooriyah S. Rizavi, Tara Teppen, Gabor L. Gaszner, Rosalinda C. Roberts, Robert R. Conley, GSK-3β Gene Expression in Human Postmortem Brain: Regional Distribution, Effects of Age and Suicide, Neurochemical Research, 2009, 34, 2, 274

    CrossRef

  46. 46
    Pil-Jae Kong, Myung-Og Kil, Heejae Lee, Sung-Soo Kim, Gail V. W. Johnson, Wanjoo Chun, Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line, Neurological Research, 2009, 31, 1, 77

    CrossRef

  47. 47
    Gislaine T. Rezin, Graziela Amboni, Alexandra I. Zugno, João Quevedo, Emilio L. Streck, Mitochondrial Dysfunction and Psychiatric Disorders, Neurochemical Research, 2009, 34, 6, 1021

    CrossRef

  48. 48
    Alexandra I. Zugno, Samira S. Valvassori, Emilene B. S. Scherer, Cristiane Mattos, Cristiane Matté, Camila L. Ferreira, Gislaine T. Rezin, Angela T. S. Wyse, João Quevedo, Emilio L. Streck, Na+,K+-ATPase activity in an animal model of mania, Journal of Neural Transmission, 2009, 116, 4, 431

    CrossRef

  49. 49
    Emilio L. Streck, Graziela Amboni, Giselli Scaini, Priscila B. Di-Pietro, Gislaine T. Rezin, Samira S. Valvassori, Gabrielle Luz, Flávio Kapczinski, João Quevedo, Brain creatine kinase activity in an animal model of mania, Life Sciences, 2008, 82, 7-8, 424

    CrossRef

  50. 50
    Julio C. Walz, Benício N. Frey, Ana C. Andreazza, Keila M. Ceresér, Alice A. Cacilhas, Samira S. Valvassori, João Quevedo, Flávio Kapczinski, Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania, Journal of Psychiatric Research, 2008, 42, 5, 416

    CrossRef

  51. 51
    S-J Tsai, Y-J Liou, C-J Hong, Y W-Y Yu, T-J Chen, Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder, The Pharmacogenomics Journal, 2008, 8, 6, 384

    CrossRef

  52. 52
    Akanksha Kannoji, Samiron Phukan, V Sudher Babu, Vitukudi N Balaji, GSK3β: A master switch and a promising target, Expert Opinion on Therapeutic Targets, 2008, 12, 11, 1443

    CrossRef

  53. 53
    E M Wexler, D H Geschwind, T D Palmer, Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation, Molecular Psychiatry, 2008, 13, 3, 285

    CrossRef

  54. 54
    K. Schindowski, K. Belarbi, L. Buée, Neurotrophic factors in Alzheimer’s disease: role of axonal transport, Genes, Brain and Behavior, 2008, 7,
  55. 55
    Takaaki Nishimoto, Takeshi Kihara, Akinori Akaike, Tetsuhiro Niidome, Hachiro Sugimoto, α-Amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3β, Journal of Neuroscience Research, 2008, 86, 5
  56. 56
    Andrew McQuillin, Mie Rizig, Hugh M.D. Gurling, A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder, Pharmacogenetics and Genomics, 2007, 17, 8, 605

    CrossRef

  57. 57
    Rodrigo Machado-Vieira, Marcelo O. Dietrich, Renata Leke, Vitor H. Cereser, Vanessa Zanatto, Flavio Kapczinski, Diogo O. Souza, Luis V. Portela, Valentim Gentil, Decreased Plasma Brain Derived Neurotrophic Factor Levels in Unmedicated Bipolar Patients During Manic Episode, Biological Psychiatry, 2007, 61, 2, 142

    CrossRef

  58. 58
    Cristiane Corrêa, Graziela Amboni, Lara Clemes Assis, Márcio R. Martins, Flávio Kapczinski, Emilio L. Streck, João Quevedo, Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, 31, 4, 887

    CrossRef

  59. 59
    Michael K. Rowe, Charlotte Wiest, De-Maw Chuang, GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder, Neuroscience & Biobehavioral Reviews, 2007, 31, 6, 920

    CrossRef

  60. 60
    Zhengquan Mao, Liqin Liu, Rusheng Zhang, Xiaohua Li, Lithium Reduces FoxO3a Transcriptional Activity by Decreasing Its Intracellular Content, Biological Psychiatry, 2007, 62, 12, 1423

    CrossRef

  61. 61
    Mazda Adli, Dorothea L. Hollinde, Thomas Stamm, Katja Wiethoff, Martina Tsahuridu, Julia Kirchheiner, Andreas Heinz, Michael Bauer, Response to Lithium Augmentation in Depression is Associated with the Glycogen Synthase Kinase 3-Beta −50T/C Single Nucleotide Polymorphism, Biological Psychiatry, 2007, 62, 11, 1295

    CrossRef

  62. 62
    J. T. Coyle, What can a clock mutation in mice tell us about bipolar disorder?, Proceedings of the National Academy of Sciences, 2007, 104, 15, 6097

    CrossRef

  63. 63
    Guang Chen, Husseini K. Manji, Bipolar Disorder: Basic Mechanisms and Therapeutic Implications, 2007,

    CrossRef

  64. 64
    Leandro Michelon, Ivanor Meira-Lima, Quirino Cordeiro, Karen Miguita, Gerome Breen, David Collier, Homero Vallada, Association study of the INPP1, 5HTT, BDNF, AP-2β and GSK-3β GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder, Neuroscience Letters, 2006, 403, 3, 288

    CrossRef

  65. 65
    Benício N. Frey, Ana C. Andreazza, Keila M.M. Ceresér, Márcio R. Martins, Samira S. Valvassori, Gislaine Z. Réus, João Quevedo, Flávio Kapczinski, Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania, Life Sciences, 2006, 79, 3, 281

    CrossRef

  66. 66
    Mark J. Millan, Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application, Pharmacology & Therapeutics, 2006, 110, 2, 135

    CrossRef

  67. 67
    Tomi Rantamäki, Juha E.A. Knuuttila, Marie-Estelle Hokkanen, Eero Castrén, The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex, Neuropharmacology, 2006, 50, 4, 421

    CrossRef

  68. 68
    Guang Chen, Husseini K Manji, The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers, Current Opinion in Psychiatry, 2006, 19, 3, 313

    CrossRef

  69. 69
    Evan Elliott, Roee Atlas, Aya Lange, Irith Ginzburg, Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3Kinase signalling mechanism, European Journal of Neuroscience, 2005, 22, 5
  70. 70
    Elena Di Daniel, Anne W Mudge, Peter R Maycox, Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons, Bipolar Disorders, 2005, 7, 1
  71. 71
    Myoung-Sun Roh, Tae-Yeon Eom, Anna A. Zmijewska, Patrizia De Sarno, Kevin A. Roth, Richard S. Jope, Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: Protection by mood stabilizers and imipramine, Biological Psychiatry, 2005, 57, 3, 278

    CrossRef

  72. 72
    Francesco Benedetti, Alessandro Serretti, Adriana Pontiggia, Alessandro Bernasconi, Cristina Lorenzi, Cristina Colombo, Enrico Smeraldi, Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β −50 T/C SNP, Neuroscience Letters, 2005, 376, 1, 51

    CrossRef

  73. 73
    Charles H. Large, Elizabeth L. Webster, Donald C. Goff, The potential role of lamotrigine in schizophrenia, Psychopharmacology, 2005, 181, 3, 415

    CrossRef

  74. 74
    Francesco Benedetti, Alessandro Serretti, Cristina Colombo, Cristina Lorenzi, Viviana Tubazio, Enrico Smeraldi, A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression, Neuroscience Letters, 2004, 368, 2, 123

    CrossRef

  75. 75
    Asla Pitkänen, Hana Kubova, Antiepileptic drugs in neuroprotection, Expert Opinion on Pharmacotherapy, 2004, 5, 4, 777

    CrossRef

  76. 76
    Fokko J Bosker, Ben H C Westerink, Thomas I F H Cremers, Marjolein Gerrits, Marieke G C van der Hart, Sjoukje D Kuipers, Gieta van der Pompe, Gert J ter Horst, Johan A den Boer, Jakob Korf, Future Antidepressants, CNS Drugs, 2004, 18, 11, 705

    CrossRef

  77. 77
    Jin Seuk Kim, Mi-Yoon Chang, In Tag Yu, Ju Hee Kim, Sang-Hun Lee, Yong-Sung Lee, Hyeon Son, Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo, Journal of Neurochemistry, 2004, 89, 2
  78. 78
    Agnieszka Basta-Kaim, Bogusława Budziszewska, Lucylla Jaworska-Feil, Magdalena Tetich, Marta Kubera, Monika Leśkiewicz, Władysław Lasoń, Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells, European Journal of Pharmacology, 2004, 495, 2-3, 103

    CrossRef

  79. 79
    Oksana Kaidanovich-Beilin, Anat Milman, Abraham Weizman, Chaim G Pick, Hagit Eldar-Finkelman, Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus, Biological Psychiatry, 2004, 55, 8, 781

    CrossRef

  80. 80
    Wawa Zhu, Gautam N Bijur, Nathan A Styles, Xiaohua Li, Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells, Molecular Brain Research, 2004, 126, 1, 45

    CrossRef

  81. 81
    Michael A Rogawski, Wolfgang Löscher, The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions, Nature Medicine, 2004, 10, 7, 685

    CrossRef

  82. 82
    Anne Jämsä, Kristina Hasslund, Richard F Cowburn, Anders Bäckström, Mervi Vasänge, The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylation, Biochemical and Biophysical Research Communications, 2004, 319, 3, 993

    CrossRef

  83. 83
    Torsten M Madsen, Samuel S Newton, Molly E Eaton, David S Russell, Ronald S Duman, Chronic electroconvulsive seizure up-regulates β-catenin expression in rat hippocampus: role in adult neurogenesis, Biological Psychiatry, 2003, 54, 10, 1006

    CrossRef

  84. 84
    Joseph T Coyle, Ronald S Duman, Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments, Neuron, 2003, 38, 2, 157

    CrossRef